OSCR Form 144: Insider sold 34,120 shares

OSCR reported insider sale activity and option-related exercises.

Rhea-AI Filing Summary

OSCR reported insider sale activity and option-related exercises. A reported sale of 34,120 shares on 06/02/2026 generated $748,633.08. The filing also lists planned/related option exercises: 660,000 shares tied to an Exercise of Stock Options dated 06/23/2026 and 220,000 shares from a prior exercise dated 11/16/2023.

Key Figures

Shares sold (reported): 34,120 shares Proceeds from sale: $748,633.08 Option exercise (planned/listed): 660,000 shares +1 more

4 metrics

Shares sold (reported) 34,120 shares sale dated 06/02/2026

Proceeds from sale $748,633.08 sale dated 06/02/2026

Option exercise (planned/listed) 660,000 shares Exercise of Stock Options dated 06/23/2026

Prior exercised options 220,000 shares Previously exercised stock options dated 11/16/2023

Key Terms

Form 144, Exercise of Stock Options, Issuer

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Stock Options financial

"Common | 06/23/2026 | Exercise of Stock Options"

Issuer regulatory

"Exercise of Stock Options | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 144 for OSCR disclose about recent insider sales?

The filing discloses a sale of 34,120 shares on 06/02/2026, producing $748,633.08. This transaction is recorded on the Form 144 as a reported sale by an affiliated party.

Does the Form 144 show any option exercises for OSCR?

Yes. The filing lists an Exercise of Stock Options dated 06/23/2026 for 660,000 shares and a prior exercise dated 11/16/2023 for 220,000 shares as shown in the securities schedule.

Who is the reported seller on the Form 144 for OSCR?

The seller listed is MARIO SCHLOSSER with an address at 75 Varick Street, 5th Floor, New York, NY 10013, appearing next to the recorded sale of 34,120 shares on 06/02/2026.

What method of sale or consideration is shown for the transactions in OSCR's filing?

The filing entries reference cash as the consideration method associated with the recorded option exercises and the sale entry. Specific broker/dealer execution details are not provided in the excerpt.

Do the Form 144 entries state who receives proceeds from the option exercises?

The excerpt identifies entries as Issuer in the securities table for the option-related lines, but it does not state a detailed allocation of proceeds beyond those labels in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2026 - 04:24 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001844320
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Oscar Health, Inc.
SEC File Number	001-40154
Address of Issuer	75 Varick Street, 5th Floor New York NEW YORK 10013
Phone	6464033677
Name of Person for Whose Account the Securities are To Be Sold	MARIO SCHLOSSER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	880000	25115200.00	265902000	06/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/23/2026	Exercise of Stock Options	Issuer			660000	06/23/2026	Cash
Common	11/16/2023	Previously Exercised Stock Options	Issuer			220000	11/16/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARIO SCHLOSSER 75 Varick Street, 5th Floor New York NY 10013	Common	06/02/2026	34120	748633.08

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the previous exercise of stock options during the period of 11/16/2023 through 11/12/2025.
Date of Notice	06/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mario Schlosser
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)